Acrux Limited ACR.AX · Stock Open Acrux Limited in new tab
Acrux Limited Analysis (ACR.AX)
Is Acrux Limited a good investment? Acrux Limited (ACR.AX) is currently trading at 0.0100 AUD.
Earnings Schedule: Acrux Limited is expected to release its next earnings report on March 2, 2027.
Investor FAQ
Does Acrux Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is Acrux Limited?
Acrux Limited is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be March 2, 2027. The company currently has a trailing EPS of -0.01.
Company Profile
Acrux Limited, together with its subsidiaries, develops and commercializes topically applied pharmaceutical products in Australia, the United States, Europe, and internationally. The company offers Dapsone 7.5% and 5% gels for the treatment of acne vulgaris; Nitroglycerine 0.4% ointments for the treatment of moderate to severe pain associated with chronic anal fissure; Lidocaine and Prilocaine creams USP 2.5% for local analgesia and pre-treatment for infiltration anesthesia; and estradiol transdermal sprays for women for the treatment of moderate to severe hot flushes associated with menopause under the Lenzetto and Evamist brand names. It also provides laboratory and product development services, including in vitro release testing; formulation development; stability and quality check; analytical; generic and pharma development; regulatory; project management and technology transfer; consulting; and co-development services. The company was incorporated in 1998 and is based in West Melbourne, Australia.
| Year | Total Dividends |
|---|---|
| ▸2015 |
0.06 AUD
|
| Sept. 3, 2015 | 0.0600 |
| ▸2014 |
0.20 AUD
|
| Sept. 22, 2014 | 0.0800 |
| March 20, 2014 | 0.1200 |
| ▸2013 |
0.08 AUD
|
| Sept. 23, 2013 | 0.0800 |
| ▸2012 |
0.08 AUD
|
| Sept. 24, 2012 | 0.0800 |
| ▸2011 |
0.60 AUD
|
| April 19, 2011 | 0.6000 |
Community Discussion